Fluticasone Propionate Powder, Metered
Product Images NDC 66993-790

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 66993-790). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluticasone Propionate Chemical Structure (Fluticasone Propionate Diskus Spl Graphic 01)

Chemical structure of fluticasone propionate, the active ingredient in FLUTICASONE PROPIONATE DISKUS, a human prescription drug delivered as a metered powder for respiratory inhalation.*

FDA Label Image

Figure 1 (Fluticasone Propionate Diskus Spl Graphic 02)

Line graph showing the percentage change from baseline in FEV1 over 12 weeks for Fluticasone Propionate DISKUS 100 mcg twice daily compared to placebo. The vertical axis denotes percentage change in FEV1, and the horizontal axis shows the weeks from 0 to 12, illustrating a higher and sustained increase in FEV1 for fluticasone propionate compared to placebo throughout the study period.*

FDA Label Image

Figure 2 (Fluticasone Propionate Diskus Spl Graphic 03)

Line graph depicting the percentage change from baseline in FEV1 over 12 weeks comparing Fluticasone Propionate Diskus 100 mcg twice daily and placebo. The x-axis represents weeks from 0 to 12 and an endpoint, while the y-axis shows percentage change. Fluticasone Propionate Diskus demonstrates a higher increase in FEV1 compared to placebo throughout the study period.*

FDA Label Image

Figure 3 (Fluticasone Propionate Diskus Spl Graphic 04)

A line graph depicting percentage change from baseline in FEV1 over 12 weeks. Two lines represent Fluticasone Propionate DISKUS 250 mcg twice daily and placebo. The vertical axis shows percent change, and the horizontal axis shows weeks from 0 to 12, including an endpoint measurement.*

FDA Label Image

Figure 4 (Fluticasone Propionate Diskus Spl Graphic 05)

A line graph showing the percentage change from baseline in FEV1 over 12 weeks comparing Fluticasone Propionate DISKUS 500 mcg twice daily versus placebo. The x-axis represents weeks from 0 to 12, and the y-axis shows the percent change in FEV1. The Fluticasone group shows a higher increase in FEV1 percentage over time compared to placebo.*

FDA Label Image

Figure A (Fluticasone Propionate Diskus Spl Graphic 06)

Illustration of a Fluticasone Propionate Diskus inhaler device marked with parts labeled: Outer Case, Mouthpiece, Lever, Counter, and Thumb Grip. The central label indicates it contains Fluticasone Propionate inhalation powder 100 mcg with 60 blisters.*

FDA Label Image

Figure B (Fluticasone Propionate Diskus Spl Graphic 07)

An instructional illustration showing how to operate the FLUTICASONE PROPIONATE DISKUS inhaler device. A hand holds the inhaler, with an arrow indicating the direction to slide the lever to prepare the dose for inhalation.*

FDA Label Image

Figure C (Fluticasone Propionate Diskus Spl Graphic 08)

An instructional illustration showing hands holding and operating a Fluticasone Propionate Diskus inhaler device. The image includes a white arrow indicating the direction to open or activate the inhaler for use.*

FDA Label Image

Figure D (Fluticasone Propionate Diskus Spl Graphic 09)

Illustration showing a woman using a red fluticasone propionate inhaler device. She is holding the device near her mouth, appearing to exhale or prepare to inhale the medication from the powder inhaler.*

FDA Label Image

Figure E (Fluticasone Propionate Diskus Spl Graphic 10)

Illustration showing a woman using a red fluticasone propionate metered dose inhaler device, demonstrating the respiratory inhalation administration of the powder medication.*

FDA Label Image

Figure F (Fluticasone Propionate Diskus Spl Graphic 11)

An instructional illustration showing hands holding a fluticasone propionate metered dose inhaler (Diskus). A large horizontal arrow points leftward, indicating the direction to slide the inhaler’s lever to prepare it for use.*

FDA Label Image

Figure G (Fluticasone Propionate Diskus Spl Graphic 12)

An illustration showing a woman rinsing her mouth and spitting into a sink, with a glass of water nearby. This instructional image likely relates to post-inhalation oral hygiene instructions for inhaled respiratory medications.*

FDA Label Image

Figure H (Fluticasone Propionate Diskus Spl Graphic 13)

FLUTICASONE PROPIONATE DISKUS 100 mcg metered powder inhalation device label shows a circular white label indicating 60 blisters with fluticasone propionate inhalation powder, strength 100 mcg. The device is reddish-orange plastic with a circular medication indicator window displaying the number 5.*

FDA Label Image

Fluticasone Propionate Diskus 50 Mcg 60 Dose Carton (Fluticasone Propionate Diskus Spl Graphic 14)

Fluticasone Propionate Diskus Inhalation Powder 50 mcg metered dose by Prasco Laboratories. The label notes each blister contains 50 mcg of fluticasone propionate with lactose. Packaging includes one Diskus device with one foil strip of 60 blisters. The product is for oral inhalation only and is Rx only.*

FDA Label Image

Fluticasone Propionate Diskus 100 Mcg 60 Dose Carton (Fluticasone Propionate Diskus Spl Graphic 15)

Fluticasone Propionate Diskus 100 mcg inhalation powder packaging label from Prasco Laboratories. The label indicates it is for oral inhalation only, with each blister containing 100 mcg of fluticasone propionate. The package includes 1 Diskus device and 1 foil strip of 60 blisters. The product is Rx only.*

FDA Label Image

Fluticasone Propionate Diskus 250 Mcg 60 Dose Carton (Fluticasone Propionate Diskus Spl Graphic 16)

Fluticasone Propionate Diskus Inhalation Powder 250 mcg by Prasco Laboratories. The label highlights that it is for oral inhalation only and dispenses 250 mcg of fluticasone propionate per blister with lactose. Packaging includes one Diskus inhalation device with a foil strip of 60 blisters. Prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.